Broken heart by T-prolymphocytic leukemia

Blood. 2017 Aug 3;130(5):691. doi: 10.1182/blood-2017-05-784363.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Alemtuzumab / adverse effects
  • Alemtuzumab / therapeutic use
  • Cytokines / metabolism
  • Delayed Diagnosis
  • Fatal Outcome
  • Heart Failure / etiology*
  • Humans
  • Leukemia, Prolymphocytic, T-Cell / complications*
  • Leukemia, Prolymphocytic, T-Cell / diagnosis
  • Leukemia, Prolymphocytic, T-Cell / pathology
  • Male
  • Myocarditis / etiology*
  • Myocarditis / pathology

Substances

  • Cytokines
  • Alemtuzumab